Co-Diagnostics, Inc.
Co-Diagnostics, Inc. scores highest on Price (48) and lowest on Nitro (3). Its PosiPenta is 28.79 out of 100, weaker than most similar companies.
On the Penta Grid this week, Co-Diagnostics, Inc. is Grid #775 of 837 in the Healthcare sector in United States, and Grid #3,680 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Co-Diagnostics, Inc. | 28.79 | 48 | 40 | 3 | 32 | 21 |
| bioAffinity Technologies, Inc. | 24.07 | 36 | 40 | 10 | 17 | 17 |
| cbdMD, Inc. | 44.95 | 92 | 40 | 16 | 46 | 31 |
| Liminatus Pharma, Inc. | 13.85 | 6 | 4 | 3 | 5 | 52 |
| Jaguar Health, Inc. | 22.74 | 39 | 40 | 3 | 7 | 25 |
| Medicus Pharma Ltd. | 24.66 | 0 | 36 | 6 | 50 | 32 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.03 |
| P/B ratio | 0.36 |
EEarnings
| Trailing EPS | ₹-2475.85 |
| Forward EPS | ₹-78.61 |
NNitro
| Price | 61.94 |
| 52-week high | 4404.25 |
| 52-week low | 59.67 |
| Fall from 52-week high | 98.6% |
TTorque
| Return on equity (ROE) | -174.77% |
| Debt-to-equity | 0.14 |
AAnchor
| Beta (price swings) | 2.90 |
| Market cap | ₹43 Cr |
| Insider holding | 1.89% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Co-Diagnostics, Inc.'s PosiPenta score?
Co-Diagnostics, Inc.'s PosiPenta is 28.79 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Co-Diagnostics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Co-Diagnostics, Inc. is Grid #775 of 837 in the Healthcare sector in United States, and Grid #3,680 of 4,000 in United States.
Which PosiPenta pillar is strongest for Co-Diagnostics, Inc.?
Price (valuation), with a score of 48 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Co-Diagnostics, Inc.?
Nitro (momentum), with a score of 3 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.